Sensus Healthcare, Inc.
No SEC Form 4 filings for $SRTS in the last 30 days.
See all $SRTS insider activity →Sensus Healthcare, Inc. (SRTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 g085863_ex99-1.htm EXHIBIT 99-1 Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights Commercial Momentum Builds Following CPT Code Implementation Revenue Recognition on Eight Purchased Units Shifted to Q3 Due to Financing
Sensus Healthcare (NASDAQ: SRTS) is set to release its quarterly earnings on Thursday, 2026-02-12, with analysts expecting an EPS of $-0.07. Investors will be looking for a beat on this estimate and positive forward guidance. Historically, the company's stock has reacted significantly to earnings, with the last quarter seeing a 19.32% increase after beating EPS estimates.
Image source: The Motley Fool.Thursday, November 6, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Over the past 7 days, alphai's AI scored 1 news story mentioning SRTS (Sensus Healthcare, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent SRTS coverage spans financial news and earnings.
The filing is a timing-driven revenue miss with a stated catch-up in Q3, plus a reimbursement catalyst via a proposed CMS 26% hospital-based delivery code increase.
Sensus Healthcare is scheduled to release quarterly earnings on 2026-02-12. Analysts expect an EPS of -0.07, and the company's stock has historically reacted strongly to earnings surprises, with a notable 19.32% increase after beating estimates in the previous quarter.
SRTS sentiment remains neutral; no clear bullish or bearish signals from the transcript.
Sensus Healthcare (SRTS) reported a significant earnings and revenue beat for Q3 2025, with surprises of +50.00% and +48.36% respectively. This indicates strong operational performance and potential positive momentum.
SRTS experienced a -1.83% decline in the latest trading session, indicating short-term weakness.
alphai scores every news story that mentions SRTS with an AI model for sentiment and relevance, and aggregates insider trades from Sensus Healthcare, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Sensus Healthcare, Inc. (SRTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 g085863_ex99-1.htm EXHIBIT 99-1 Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights Commercial Momentum Builds Following CPT Code Implementation Revenue Recognition on Eight Purchased Units Shifted to Q3 Due to Financing
6 min readSensus Healthcare (NASDAQ: SRTS) is set to release its quarterly earnings on Thursday, 2026-02-12, with analysts expecting an EPS of $-0.07. Investors will be looking for a beat on this estimate and positive forward guidance. Historically, the company's stock has reacted significantly to earnings, with the last quarter seeing a 19.32% increase after beating EPS estimates.
4 min readImage source: The Motley Fool.Thursday, November 6, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
2 min readSensus Healthcare (SRTS) delivered earnings and revenue surprises of +50.00% and +48.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
3 min readSensus Healthcare, Inc. (SRTS) concluded the recent trading session at $3.21, signifying a -1.83% move from its prior day's close.
2 min readIn the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $3.29, marking a +2.17% move from the previous day.
2 min readSensus Healthcare, Inc. (SRTS) closed the most recent trading day at $3.31, moving 4.06% from the previous trading session.
3 min readThe latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $3.45, representing a -2.82% change from its previous close.
2 min readSensus Healthcare, Inc. (SRTS) concluded the recent trading session at $3.17, signifying a +2.26% move from its prior day's close.
2 min readNEW YORK, Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ( "Sensus" or the "Company" ) SRTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
2 min read
